# Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients

> **NCT04285788** · — · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 216 (actual)

## Conditions studied

- Adenovirus Infections, Human

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04285788
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-09
- **Final completion:** 2017-01
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2022-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04285788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04285788, "Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04285788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*